Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 195,100
+4,600 (2.41%)
At close: May 14, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 40.89 trillion as of May 14, 2026. Its market cap has increased by 20.22% in one year.
Market Cap
40.89T
Enterprise Value
43.53T
Revenue
4.16T
Ranking
n/a
PE Ratio
41.87
Stock Price
195,100.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 40.89T, an increase of 39,292.88%. That is a compound annual growth rate of 40.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 40.89T | 3.25% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 67.08T |
| ALTEOGEN | 20.60T |
| Samsung Epis Holdings | 12.57T |
| Kolon TissueGene | 9.69T |
| SK Biopharmaceuticals | 7.77T |
| LigaChem Biosciences | 7.28T |
| HLB Co., Ltd. | 7.07T |
| Peptron | 6.21T |